Mining and Metals
Canadian Gold Corp. (TSXV: CGC) (OTC: STRRF)(8S8:FRA)
Interview with Michael Swistun, President & CEO […]
Month: March 2025
Featured Interviews
Alpha Cognition Inc. (NASDAQ: ACOG)
Interview with Michael McFadden, CEO […]
Featured Interviews
Soligenix (NASDAQ: SNGX) Interview with Christopher Schaber, PhD CEO and President
Interview with Christopher Schaber, PhD CEO and President […]
Featured Interviews
Kobrea Exploration Corp. (CSE: KBX) (OTCQB: KBXFF)
Interview with Rory Ritchie, VP of Exploration […]
News Feed
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
Broader protection induced by combination of COVID adenovirus vaccine plus CiVax™ compared to 2-shot mRNA vaccination series PRINCETON, N.J., March 25, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]
News Feed
Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview
Conference Call Scheduled for March 31, 2025 4:30pm ET VANCOUVER, British Columbia & DALLAS, March 19, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that […]
News Feed
Kobrea Commissions Property-Wide Airborne Magnetic & Radiometric Survey at Western Malargüe Copper Projects, Mendoza Province, Argentina
Vancouver, British Columbia–(Newsfile Corp. – March 13, 2025) – Kobrea Exploration Corp. (CSE: KBX) (FSE: F3I) (OTCQB: KBXFF) (“Kobrea” or the “Company“) announces that it has commissioned a heli-borne magnetic and radiometric survey with New-Sense […]
News Feed
HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]